International consensus sets updated framework for CAR T-cell therapy in severe autoimmune diseases

An international multidisciplinary group of 31 experts has updated consensus recommendations to guide the use of CAR T-cell therapy in patients with severe, treatment-refractory autoimmune diseases.

≈